Literature DB >> 2088325

Interferon-alpha for the hypereosinophilic syndrome.

R M Zielinski1, W D Lawrence.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2088325     DOI： 10.7326/0003-4819-113-9-716

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  10 in total

Review 1.  Interferons 1992. How much of the promise has been realised?

Authors:  M A Volz; C H Kirkpatrick
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

Review 2.  Regulation of effector and memory T-cell functions by type I interferon.

Authors:  Jonathan P Huber; J David Farrar
Journal:  Immunology       Date:  2011-02-14       Impact factor: 7.397

3.  Cardiac anesthesia in idiopathic hypereosinophilic syndrome.

Authors:  Takashi Akata; Hiroko Sakata; Kazuo Irita; Rieko Sumiyoshi; Kenji Kodama; Shosuke Takahashi
Journal:  J Anesth       Date:  1994-12       Impact factor: 2.078

Review 4.  Eosinophils: multifaceted biological properties and roles in health and disease.

Authors:  Hirohito Kita
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

Review 5.  Interferon at the crossroads of allergy and viral infections.

Authors:  Sarah R Gonzales-van Horn; J David Farrar
Journal:  J Leukoc Biol       Date:  2015-05-29       Impact factor: 4.962

Review 6.  Clinical overview of cutaneous features in hypereosinophilic syndrome.

Authors:  Sabine Gisela Plötz; Bettina Hüttig; Birgit Aigner; Christian Merkel; Knut Brockow; Cezmi Akdis; Ulf Darsow; Johannes Ring
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

7.  Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells.

Authors:  L Schandené; G F Del Prete; E Cogan; P Stordeur; A Crusiaux; B Kennes; S Romagnani; M Goldman
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

8.  Control of hypereosinophilic syndrome-associated recalcitrant coronary artery spasm by combined treatment with prednisone, imatinib mesylate and hydroxyurea.

Authors:  Joseph H Butterfield; Scott W Sharkey
Journal:  Exp Clin Cardiol       Date:  2006

9.  Successful treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate: a case report.

Authors:  D Tan; W Hwang; H J Ng; Y T Goh; P Tan
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

Review 10.  Hypereosinophilic Syndrome.

Authors:  Casey Curtis; Princess Ogbogu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 10.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.